Skip to Main Content

Grifols, S.A. (NASDAQ: GRFS) SECURITIES FRAUD INVESTIGATION

Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchasers of Grifols, S.A. ("Grifols") (NASDAQ:  GRFS) between February 28, 2019 and February 28, 2024.

On January 9, 2024, Gotham City Research issued a report alleging that Grifols manipulated its debt and EBITDA figures to artificially lower its leverage. Following the publication of the report, Grifols's American Depositary Receipts (“ADRs”) fell $2.43, or 27.93%, to close at $8.60 per ADR on January 9, 2024.

Then on February 29, 2024, Grifols announced its Q4 financial results. On the accompanying earnings call, Grifols’s CFO disclosed that free cash flow in 2024 could be zero due to “accounting stuff.”  Following this news, Grifols’s ADRs fell over 30%, to close at $7.51 per ADR on February 29, 2024.

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  

SUBMIT YOUR INFORMATION
* Denotes required field
Purchase(s)
+ Additional Purchases
Sale(s)
+ Additional Sales
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Grifols, S.A. prior to the Class Period?
Are you a current or former employee of Grifols, S.A.?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email
Submit Your Information